Omkar Pharmachem Ltd (OMKARPH) is currently trading at 6.21 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Omkar Pharmachem Limited is primarily involved in providing management and business support services within the pharmaceuticals and chemicals industry. The company, established in 1995, has recently shifted its focus from commercial pharmaceutical activities to offering support services. Although originally incorporated to operate in the pharmaceuticals and chemicals sector, it has not pursued active commercial operations since incorporation. There are no active product lines or commercial engagements mentioned, indicating a strategic repositioning towards administrative and support roles within the sector.

Over the past 52 weeks, Omkar Pharmachem Ltd has traded between a low of ₹5.66 and a high of ₹29.74. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Omkar Pharmachem Ltd has a market capitalization of approximately 6.14. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Omkar Pharmachem Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 68.22 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 6.14 Cr, Omkar Pharmachem Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Omkar Pharmachem Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Omkar Pharmachem Ltd is 68.22. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.